tiprankstipranks
Acro Biomedical Co Ltd (ACBM)
OTHER OTC:ACBM
US Market

Acro Biomedical Co (ACBM) Income Statement

Compare
11 Followers

Acro Biomedical Co Income Statement

Last quarter (Q2 2023), Acro Biomedical Co's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Acro Biomedical Co's net income was $-3.20M. See Acro Biomedical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 658.50K$ 1.20M$ 687.96K$ 193.54K
Gross Profit
$ 140.50K$ 259.50K$ 159.40K$ 12.10K
Operating Expenses
$ 16.01M$ 7.95M$ 289.87K$ 434.85K
Depreciation and Amortization
$ 0.00$ 7.69M$ 130.46K$ 422.75K
EBITDA
$ -15.87M$ -7.69M$ -130.46K$ -301.73K
Operating Income
$ -15.87M$ -7.69M$ -130.46K$ -422.75K
Other Income/Expenses
$ -1.71K$ -4.25K$ -5.08K$ -1.98K
Pretax Income
$ -15.87M$ -7.70M$ -135.54K$ -424.73K
Net Income
$ -15.87M$ -7.70M$ -117.45K$ -371.60K
Per Share Metrics
Basic EPS
$ -0.26$ -0.14$ 0.00$ -0.01
Diluted EPS
$ -0.26$ -0.14$ 0.00$ -0.01
Weighted Average Shares Outstanding
60.04M 53.84M 47.76M 47.76M
Weighted Average Shares Outstanding (Diluted)
60.04M 53.84M 47.76M 47.76M
Currency in USD

Acro Biomedical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis